glp-1 and bone density Use Associated with Lower Osteoporosis Risk in Adults with Type 2 Diabetes but Higher Risk in Adults Without Diabetes GLP-1s may increase risk of
Description
Think of your gut like a garden
By promoting GLP-1 support, it helps encourage a feeling of fullness, acts as a natural appetite suppressant, and promotes weight loss management when taken before meals
Yale researchers have discovered that GLP-1 receptor agonist drugs, like Ozempic and Wegovy, may offer promising new ways of treating alcohol use disorder.
Major cardiovascular outcome trials and real-life observations have proven that glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), regardless of structural GLP-1 homology, exert clinically relevant cardiovascular protection
Unlike FDA-approved medications (e.g., Wegovy, Ozempic, Zepbound), compounded alternatives lack agency review for safety, quality, and efficacy
A study of health insurance claims found a 44% reduction in hospitalizations for GLP-1 users
